It will go after regulations that slow growth, obstruct innovators and cost American households thousands of dollars each year. Here’s hoping for success. The burden of excessive regulation is hard to ...
Elie Bahou, PharmD, senior vice president and system chief pharmacy officer at Providence, discusses strategies to improve equitable access to biologic therapies, including tiered formularies, ...